Providence Health & Services; Providence Neurological Specialties

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response	primary central nervous system lymphoma	Recruiting	Phase 2	2026-09-23		NCT06175000

Clinical trials